STOCK TITAN

eMagin Corporation to Exhibit at FLORetina ICOOR 2022 Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

eMagin Corporation (NYSE American: EMAN) announced its participation in the FLORetina ICOOR 2022, taking place from December 8-11 in Rome, Italy. The company will showcase its high-resolution OLED microdisplays tailored for medical applications, particularly in ophthalmology. These displays promise high contrast, a wide color gamut, and ultra-high resolution, making them ideal for imaging, diagnosis, and surgical education. eMagin is recognized as the only US manufacturer of OLED displays and aims to revolutionize visual technology for various sectors.

Positive
  • Participation in the FLORetina ICOOR 2022 could enhance visibility and engagement in the medical sector.
  • Demonstration of OLED microdisplays tailored for medical applications indicates a focus on innovation and market expansion.
Negative
  • None.

HOPEWELL JUNCTION, N.Y., Dec. 01, 2022 (GLOBE NEWSWIRE) -- eMagin Corporation (NYSE American: EMAN), a leader in the development, design, and manufacture of high-resolution OLED microdisplays for AR/VR and other near-eye imaging products, today announced its participation at FLORetina ICOOR 2022, the 10th International Congress on OCT and OCT Angiography, December 8-11, in Rome, Italy.

What: FLORetina ICOOR 2022
When: December 8-11
Where: Booth 44, Rome Cavalieri, A Waldorf Astoria Hotel, Congress Center, Rome

For more information and to register for the conference, visit FLORetina.com

eMagin will demonstrate OLED microdisplays suited for medical applications, including those used in ophthalmology applications like retinal surgery, imaging, diagnosis, and education. eMagin’s displays offer high-contrast, wide color gamut, ultra-high resolution, and small form factors that are ideal for medical applications.

About eMagin
eMagin is the leader in OLED microdisplay technology, enabling the visualization of digital information and imagery for world-class customers in the military, consumer, medical and industrial markets. The Company invents, engineers, and manufactures display technologies of the future and is the only manufacturer of OLED displays in the United States. eMagin's Direct Patterning Technology (dPd™) will transform the way the world consumes information. Since 2001, eMagin's microdisplays have been used in AR/VR, aircraft helmets, heads-up display systems, thermal scopes, night vision goggles, future weapon systems and a variety of other applications. For more information, please visit www.emagin.com.

Contact:

eMagin Corporation
Mark Koch, Chief Financial Officer
845-838-7900
investorrelations@emagin.com

Sharon Merrill Associates, Inc.
Nicholas Manganaro
617-542-5300
eman@investorrelations.com


FAQ

What is eMagin Corporation showcasing at FLORetina ICOOR 2022?

eMagin Corporation is showcasing high-resolution OLED microdisplays specifically designed for medical applications at FLORetina ICOOR 2022.

When is FLORetina ICOOR 2022 taking place?

FLORetina ICOOR 2022 will be held from December 8-11, 2022.

Where will eMagin be located during the FLORetina ICOOR 2022?

eMagin will be located at Booth 44, Rome Cavalieri, A Waldorf Astoria Hotel, Congress Center, Rome.

What are the features of eMagin's OLED microdisplays?

eMagin's OLED microdisplays offer high contrast, a wide color gamut, ultra-high resolution, and small form factors, making them ideal for medical applications.

eMagin Corporation

NYSE:EMAN

EMAN Rankings

EMAN Latest News

EMAN Stock Data

172.20M
77.45M
6.88%
15.98%
1.92%
Electronic Components
Technology
Link
United States
Hopewell Junction